Allozymes Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 31

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $15M

  • Investors
  • 16

Allozymes General Information

Description

Developer of microfluidic technology designed to support the development and testing of enzymes. The company's platform helps employ molecular biology and process engineering to produce proteins and deliver precise proteins in the form of pure enzymes for the target application, enabling clients to accelerate custom enzyme development and develop novel, sustainable natural products.

Contact Information

Website
www.allozymes.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 79 Science Park Drive Cintech IV
  • Number 06-05
  • Singapore, 118264
  • Singapore
Primary Industry
Discovery Tools (Healthcare)
Vertical(s)
Life Sciences
Corporate Office
  • 79 Science Park Drive Cintech IV
  • Number 06-05
  • Singapore, 118264
  • Singapore

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Allozymes Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC (Series A) 03-May-2024 $15M Completed Generating Revenue
8. Accelerator/Incubator 11-Nov-2022 Completed Generating Revenue
7. Seed Round 18-Apr-2022 Completed Generating Revenue
6. Grant 11-Jun-2021 Completed Startup
5. Seed Round 25-Jan-2021 Completed Startup
4. Grant 01-Jan-2021 Completed Startup
3. Accelerator/Incubator 29-Jan-2020 Completed Startup
2. Accelerator/Incubator 17-Jan-2020 Completed Startup
1. Early Stage VC Completed Startup
To view Allozymes’s complete valuation and funding history, request access »

Allozymes Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
Seed2
Seed 2,675,248 $1.22 $1.22 1x $1.22 10.43%
To view Allozymes’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Allozymes Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of microfluidic technology designed to support the development and testing of enzymes. The company's platform
Discovery Tools (Healthcare)
Singapore, Singapore
31 As of 2025

Menlo Park, CA
 

Redwood City, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Allozymes Competitors (5)

One of Allozymes’s 5 competitors is Aether Bio, a Venture Capital-Backed company based in Menlo Park, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aether Bio Venture Capital-Backed Menlo Park, CA
Codexis Formerly VC-backed Redwood City, CA
Arzeda Venture Capital-Backed Seattle, WA
Hummingbird Bioscience Venture Capital-Backed Singapore, Singapore
Solugen Venture Capital-Backed Houston, TX
You’re viewing 5 of 5 competitors. Get the full list »

Allozymes Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 2

    Pending

  • Expiring in next 12 mo

Allozymes Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202504125-D0 Methods and compositions Inactive 21-Mar-2025
WO-2024215256-A2 Methods and compositions Inactive 11-Apr-2023
EP-4702154-A2 Methods and compositions for producing a carotenoid or terpenoid Pending 11-Apr-2023
US-20260265710-A1 Methods and compositions for producing a carotenoid or terpenoid Pending 11-Apr-2023
WO-2024215256-A3 Methods and compositions for producing a carotenoid or terpenoid Inactive 11-Apr-2023 C12P23/00
To view Allozymes’s complete patent history, request access »

Allozymes Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Allozymes Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ambrosia Investments Growth/Expansion Minority
NUS Technology Holdings Asset Manager Minority
Seventure Venture Capital Minority
Thia Ventures Venture Capital Minority
StartLife Accelerator/Incubator
You’re viewing 5 of 16 investors. Get the full list »

Ready to get started?

Request a free trial

Allozymes FAQs

  • When was Allozymes founded?

    Allozymes was founded in 2019.

  • Where is Allozymes headquartered?

    Allozymes is headquartered in Singapore, Singapore.

  • What is the size of Allozymes?

    Allozymes has 31 total employees.

  • What industry is Allozymes in?

    Allozymes’s primary industry is Discovery Tools (Healthcare).

  • Is Allozymes a private or public company?

    Allozymes is a Private company.

  • What is the current valuation of Allozymes?

    The current valuation of Allozymes is .

  • What is Allozymes’s current revenue?

    The current revenue for Allozymes is .

  • How much funding has Allozymes raised over time?

    Allozymes has raised $23.3M.

  • Who are Allozymes’s investors?

    Ambrosia Investments, NUS Technology Holdings, Seventure, Thia Ventures, and StartLife are 5 of 16 investors who have invested in Allozymes.

  • Who are Allozymes’s competitors?

    Aether Bio, Codexis, Arzeda, Hummingbird Bioscience, and Solugen are competitors of Allozymes.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process